BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World's First Report: Plasmacluster Technology's Potential to Induce Brain Activation

Sharp Corporation conducted collaborative research on its Plasmacluster technology, with Dr. Goichi Hagiwara, Associate Professor, Faculty of Human Sc...

July 27, 2023 | News

Project Matty to Revolutionize Care for Children with Autism and ADHD Through AI

The co-founders' personal journeys fuel their resolve to bridge the gap in traditional treatments. Born out of one mother's determination to help her ADHD-...

July 25, 2023 | News

CRISPR Gene Editing Opens New Treatment Avenues for Alzheimer's

Two new CRISPR-based strategies offer hope for next-generation Alzheimer's treatments. One seeks to dampen the impact of the most common Alzheimer's ris...

July 17, 2023 | News

Zymedi Collaborates with National Heart, Lung, and Blood Institute to Develop ZMA001 mAb for PAH Treatment

The CRADA between Zymedi and the NHLBI will enable the organizations to collaborate together to advance the development of ZMA001. Zymedi will work...

July 03, 2023 | News

Promising Clinical Trial Data for Migraine Treatment: CER-0001, a Ketogenic Investigational Agent

A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated for the preventive treatment of migraine, was presented at t...

July 03, 2023 | News

Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons

he tiny visual systems of flying insects have inspired researchers of the Hong Kong Polytechnic University (PolyU) to develop Optoelectronic Graded Neurons...

June 28, 2023 | News

Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough

Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...

June 23, 2023 | Analysis

Psylo Partners with Daiichi Sankyo for Non-Hallucinogenic Psychiatric Therapies

Biotech start-up, Psylo, announced that it has entered into a Sponsored Research Agreement with global Japanese pharmaceutical company, Daiichi ...

June 23, 2023 | News

PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics

Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio Agreement to utilize PrecisionLife’s combi...

June 16, 2023 | News

GC Genome Discovers Gut Microbiome Link to High Blood Pressure in New Study

GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a study in Frontiers in Microbiomes. This study demonstrate...

June 15, 2023 | News

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Parkinson's Disease Collaboration

HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. These mission-aligned companies are collaborating to develop small...

June 13, 2023 | News

Coya Therapeutics Shows Neuroinflammation Decrease with COYA 301 in Alzheimer's

- Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to mod...

June 08, 2023 | News

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...

May 26, 2023 | News

Healint announces collaboration with Saitama Medical University Hospital in Japan to verify AI diagnosis of migraine

Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...

April 28, 2023 | News

Stay Connected